pharm 48311807 iv admixturesash
TRANSCRIPT
-
8/14/2019 Pharm 48311807 IV Admixturesash
1/7
1
PHARMACY IV ADMIXTURE
Pharmacy 483
January 18, 2007
Kim Donnelly
Affiliate Assistant Professor
Pharmacist is responsible for ensuring that
compounded sterile preparations are
properly prepared, labeled, stored,
dispensed and delivered.
USP
ASHP
NABP
JCAHO
Centralized IV Admixture
Service
Economical
Batch preparation
Reduce personnel time
Enhanced safety with standardizedsolutions.
Double check process on all preparedsolutions.
Cleaner, more controlled environment.
-
8/14/2019 Pharm 48311807 IV Admixturesash
2/7
2
USP-797
New standards effective Jan 2004 but undercontinual revision.
Standards will be enforced by Boards ofPharmacy.
Sterile product preparations are categorizedas high, medium or low risk based on thepotential for microbial, chemical andphysical contamination.
Buffer Room (Prep Area)
Must be ISO Class 7 (Class 10,000)
Prepared in a ISO Class 5 (Class 100)
laminar airflow hood.
Positive pressure room with HEPA filtered
air.
Access is restricted in Buffer area.
ISO Class 7
Also referred to as a Class 10,000
environment.
Air particle count does not exceed 10,000
particles 0.5 microns or larger per cubic
foot of air.
-
8/14/2019 Pharm 48311807 IV Admixturesash
3/7
3
Buffer Rooms
Walls, floors, ceiling should be smooth, no
cracks and crevices.
Ceilings should be sealed.
Floors coved.
No sinks in Buffer area.
Only non-shedding paper products in area.
Ante-Room or Ante-Area
Gowning and hand-washing.
No food or beverages.
No carts moving back and forth from buffer
zone to ante-area.
Wipe down of products before introducing
into the buffer area.
Laminar Flow Hoods
Horizontal
Vertical
Barrier Isolators
Certified every 6 mo.
ISO Class 5 (Class
100) environment.
-
8/14/2019 Pharm 48311807 IV Admixturesash
4/7
4
Gowning
Remove make-up, jewelry.
Scrub hands and arms to elbow.
Non-shedding gown, knee length with a zip
or snap front.
Shoe covers, hair covers, face mask and
gloves.
Risk Classification
Non-sterile ingredients or
open-system transfers.
High-Risk Compounding
Admixtures using
multiple additives or
batch preparations.
Medium-Risk
Compounding
Simple admixtures using
closed system transfer
methods.
Low-Risk Compounding
Beyond-Use Dating
Storage period before administration.
When compounded sterile products are
stored for prolonged periods of time there is
potential for microbial growth and pyrogen
formation.
Chemical stability
Microbial sterility
-
8/14/2019 Pharm 48311807 IV Admixturesash
5/7
5
Beyond-Use Dating
45 days3 days24 hrsHigh
45 days9 days30 hrsMedium
45 days14 days48 hrsLow
FreezerRefrigerationRoom TempRisk Level
Personnel
Documented education, training and
competency.
Didactic training.
Competency tests.
Return demonstration/observation.
Media-fill testing of aseptic manipulative skills.
Media-fill test kit
-
8/14/2019 Pharm 48311807 IV Admixturesash
6/7
6
Media-fill challenge testing
Sterile bacterial culture medium transferredvia a variety of aseptic manipulations
Test should represent the most challengingproducts made for a particular risk level
Products are monitored for microbialgrowth, indicated by visual turbidity, for 14days
Done annually and for new employees
Environmental Controls and
Testing
Routine cleaning schedule.
Laminar flow hood certification every 6
months.
Particle-count testing.
Electric air samplers or agar settling plates.
Total Parenteral Nutrition
Multiple ingredients (1-3 liters).
Standard Operating Procedures.
Automated Compounders
Improve accuracy and efficiency.
Accuracy verified by weight, volume.
Some hospitals have decided to outsource thesepreparations to compounding centers.
-
8/14/2019 Pharm 48311807 IV Admixturesash
7/7
7
Hazardous Drugs
NIOSH (National Institute for Occupational
Safety and Health) Guidelines, ASHP Guidelines
for employee safety.
Vertical flow hood vented to the outside to protect
operator.
Pharmacy attaches tubing to reduce RN exposure.
Negative pressure room.
Separate storage/Receiving procedures.
Resources
United States Pharmacopeia (USP) web site:
www.usp.org
American Society of Health-System Pharmacists
(ASHP) web site: www.ashp.org
Kastango ES, Blueprint for implementing USP
chapter 797 for compounding sterile preparations,
AmJ Health-Syst Pharm. 2005;62:1271-88.